+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

SHIV-IIIB vaccine study using DNA primes and alternative boosts Neutralizing antibody independent protection by a DNA prime and a recombinant fowl box boost



SHIV-IIIB vaccine study using DNA primes and alternative boosts Neutralizing antibody independent protection by a DNA prime and a recombinant fowl box boost



Journal of Medical Primatology 28(4-5): 285




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035689215

Download citation: RISBibTeXText


Related references

Inclusion of an env protein boost with a DNA/MVA prime-boost vaccine; impact on humoral and cellular immunogenicity and protection from SHIV challenge. Journal of Medical Primatology 31(4-5): 267-268, 2002

Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells. Vaccine 25(11): 2128-2138, 2007

Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge. Vaccine 30(10): 1830-1840, 2012

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers. Immunity 50(1): 241-252.E6, 2019

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects. Plos one 11(8): E0160341, 2016

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E. Vaccine 30(5): 832-836, 2012

Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model. Vaccine 23(30): 3925-3936, 2005

Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus. Plos one 6(1): E16563, 2011

Immunity and prior protection against homologous SHIV-IIIB challenge failed to protect against highly pathogenic SHIV KU-1 or SHIV 896P infection, but resulted in reduced viral load and CD4 cell recovery. Journal of Medical Primatology 31(4-5): 302, 2002

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. Plos Pathogens 5(5): E1000433, 2009

Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology 250(2): 293-301, 1998

Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis. Plos one 8(11): E78639, 2013

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. Journal of General Virology 85(Pt 8): 2407-2419, 2004

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172). Journal of Infectious Diseases 201(4): 600-607, 2010

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Virology 294(2): 270-281, 2002